JBCHEPHARM stock news on Anadi Algo News

Monday, June 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
Stock Landing|0 matching stories

JBCHEPHARM Share Price, Latest News & Sentiment

Latest AI-analyzed news for JBCHEPHARM, along with saved share-price context, sentiment, quarterly filing summary, and related names in one page.

Stock Coverage Hub

JBCHEPHARM News Today

Emerging stock coverage

JBCHEPHARM is being tracked here as a stock-news cluster with recent headlines, sentiment, related sectors and linked names in one place.

Coverage
0
recent stories
Sources
0
distinct publishers
Bias Split
0 bullish / 0 bearish
0 neutral stories
Window
0d
recent coverage span
Saved Quote Snapshot

JBCHEPHARM

Last Updated
23 May 2026
Price
NA
NA
52W Range
NA - NA
exchange snapshot
PE / VWAP
PE NA
VWAP NA
Trend Read
bullish
Bullish stack · EMA 5 > 9 > 21 > 50
Business Context
Industry: NA
Sector Trail: NA
Listing Date: NA
Market Structure
F&O Eligible: No
Indices: NA
Snapshot Source: mcp+nse
Quarterly Read

Quarter ended 31 Dec 2024

Consolidated results
What This Quarter Says

JBCHEPHARM's latest financial report shows the company made Rs 963.49 crore in sales and a profit of Rs 162.49 crore. This filing is on record. These numbers tell us how much money the company earned and how much profit it kept.

Revenue
Rs 963.49 cr
up 5.5% vs previous filing
Profit
Rs 162.49 cr
up 3.9% vs previous filing
EPS / Finance Cost
EPS 10.46
Finance cost Rs 2.58 cr
Filing Context
Filed 5 Feb 2025, 5:44 pm
Figures are taken from the saved exchange filing, not from a live request.
Quick Reader Notes
  • Revenue this quarter: Rs 963.49 cr, up 5.5% vs previous filing.
  • Profit this quarter: Rs 162.49 cr, up 3.9% vs previous filing.
  • EPS gives a quick sense of per-share earnings: 10.46.
How To Read This

Treat this block as a saved quarter snapshot. First see whether revenue and profit are improving, then read the latest news below to judge whether recent headlines support that trend or work against it.

Top Themes

Theme clustering will appear here as more analyzed stories accumulate.

Related Stocks

Peer names will show up here once more related-stock mentions appear in coverage.

Key People

Management and deal-maker mentions will appear here when they show up in recent stories.

JBCHEPHARM FAQ

Why is JBCHEPHARM in the news right now?

JBCHEPHARM has appeared across 0 recent stories from 0 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.

Is JBCHEPHARM coverage bullish or bearish right now?

JBCHEPHARM coverage is currently mixed, with 0 bullish, 0 bearish, and 0 neutral analyzed stories in the recent window.

Which themes are moving with JBCHEPHARM?

Recent JBCHEPHARM coverage is clustering around the broader market. Related names showing up alongside JBCHEPHARM include the wider peer basket.

How should I use this JBCHEPHARM news page?

Use this page as a coverage hub for JBCHEPHARM: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.

Workflow View

Use JBCHEPHARM coverage to build a cleaner watchlist.

A stock page is most useful when it helps you slow down, compare headlines, and separate one-off noise from a repeatable setup.

This is here if you want to go deeper, not as a push.Explore Anadi

No recent stories for JBCHEPHARM

Try another stock symbol or use the main search for broader market coverage.